2 completed, 2 recruiting. 3 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Drug Refractory Epilepsy: new trials by email Literature Review of Drug Refractory Epilepsy trials Research Report on Drug Refractory Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables UNEEG SubQ device, seizure forecasts, nasal diazepam, Preventative Medication (PM) - Focal Epilepsy, Generalized Seizure | Early Phase 1 | Recruiting | Mayo Clinic | 12 | 2026-01-20 | 2026-09-25 |
| Focused Ultrasound for Drug-resistant Epilepsy Exablate 4000 Transcranial MRgfUS System - Focused Ultrasound, MR-guided FUS | Not applicable | Recruiting | Taipei Veterans General Hospital, Taiwan | 10 | 2024-01-01 | 2026-10-16 |
| cTBS Targeting Cerebellum for Drug-refractory Epilepsy cTBS First, Pseudo-stimulation First - Drug Refractory Epilepsy | Not applicable | Completed | Xijing Hospital | 44 | 2021-08-02 | 2023-01-05 |
| Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy NaviFUS System - Drug Resistant Epilepsy, Epilepsy, Drug Resistant | Not applicable | Completed | NaviFUS Corporation | 6 | 2019-06-17 | 2020-11-13 |
Drug Resistant Epilepsy (4) · Epilepsies, Partial (1) · Seizures (1)
Brain Diseases (4) · Central Nervous System Diseases (4) · Epilepsy (4) · Nervous System Diseases (4) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Mayo Clinic (1) · NaviFUS Corporation (1) · Taipei Veterans General Hospital, Taiwan (1) · Xijing Hospital (1)
Taiwan (2) · China (1) · United States (1)
Benjamin Brinkmann, PhD (1) · Cheng-Chia Lee, MD. PhD. (1) · Gregory A Worrell, MD, PhD (1) · Hsiang-Yu Yu, M.D. (1) · Jamie J Van Gompel, MD (1)
UG3NS123066-02 (1)